Background: While several efficacy trials have demonstrated diabetes risk reduction through targeting key lifestyle behaviours, there is a significant evidence gap in relation to the successful implementation of such interventions in low- and middle-income countries (LMICs). This paper evaluates the implementation of a cluster randomised controlled trial of a group-based lifestyle intervention among individuals at high-risk of developing type 2 diabetes mellitus (T2DM) in the state of Kerala, India. Our aim is to uncover provider-, participant- and community-level factors salient to successful implementation and transferable to other LMICs. Methods: The 12-month intervention program consisted of (1) a group-based peer-support program consis...
Background: Type 2 diabetes mellitus (T2DM) is now one of the leading causes of disease-related deat...
BACKGROUND: Data on the cost-effectiveness of lifestyle-based diabetes prevention programs are mostl...
© 2016 Dr. Sathish ThirunavukkarasuGlobally, 415 million people are estimated to have type 2 diabete...
Background: While several efficacy trials have demonstrated diabetes risk reduction through targetin...
Background: While several efficacy trials have demonstrated diabetes risk reduction through targetin...
Abstract Background While several efficacy trials have demonstrated diabetes risk reduction through ...
BACKGROUND: India currently has more than 60 million people with Type 2 Diabetes Mellitus (T2DM) and...
Abstract: Background: India currently has more than 60 million people with Type 2 Diabetes Mellitus ...
The major efficacy trials on diabetes prevention have used resource-intensive approaches to identify...
Background: The major efficacy trials on diabetes prevention have used resource-intensive approaches...
BACKGROUND: The major efficacy trials on diabetes prevention have used resource-intensive approaches...
Background: The major efficacy trials on diabetes prevention have used resource-intensive approaches...
BackgroundThe major efficacy trials on diabetes prevention have used resource-intensive approaches t...
BACKGROUND: Type 2 diabetes mellitus (T2DM) is now one of the leading causes of disease-related deat...
Abstract Background Type 2 Diabetes Mellitus (T2DM) has become a major public health challenge in In...
Background: Type 2 diabetes mellitus (T2DM) is now one of the leading causes of disease-related deat...
BACKGROUND: Data on the cost-effectiveness of lifestyle-based diabetes prevention programs are mostl...
© 2016 Dr. Sathish ThirunavukkarasuGlobally, 415 million people are estimated to have type 2 diabete...
Background: While several efficacy trials have demonstrated diabetes risk reduction through targetin...
Background: While several efficacy trials have demonstrated diabetes risk reduction through targetin...
Abstract Background While several efficacy trials have demonstrated diabetes risk reduction through ...
BACKGROUND: India currently has more than 60 million people with Type 2 Diabetes Mellitus (T2DM) and...
Abstract: Background: India currently has more than 60 million people with Type 2 Diabetes Mellitus ...
The major efficacy trials on diabetes prevention have used resource-intensive approaches to identify...
Background: The major efficacy trials on diabetes prevention have used resource-intensive approaches...
BACKGROUND: The major efficacy trials on diabetes prevention have used resource-intensive approaches...
Background: The major efficacy trials on diabetes prevention have used resource-intensive approaches...
BackgroundThe major efficacy trials on diabetes prevention have used resource-intensive approaches t...
BACKGROUND: Type 2 diabetes mellitus (T2DM) is now one of the leading causes of disease-related deat...
Abstract Background Type 2 Diabetes Mellitus (T2DM) has become a major public health challenge in In...
Background: Type 2 diabetes mellitus (T2DM) is now one of the leading causes of disease-related deat...
BACKGROUND: Data on the cost-effectiveness of lifestyle-based diabetes prevention programs are mostl...
© 2016 Dr. Sathish ThirunavukkarasuGlobally, 415 million people are estimated to have type 2 diabete...